Search Results 291-300 of 16408 for glomerulonephritis.

  1. Polycystic kidney disease - Doctors and departments - Mayo Clinic

    Learn how treatments and lifestyle changes might help reduce kidney damage from this disease.

  2. Polycystic kidney disease - Care at Mayo Clinic

    This means that our PKD teams offer multidisciplinary, personalized care, innovative therapies and access to clinical trials. Polycystic kidney disease clinical ...

  3. Controlled Trial Evaluating Avacopan in C3 Glomerulopathy - Mayo Clinic

    evidence of proliferative glomerulonephritis (mesangial hypercellularity of greater than 3 mesangial cells per mesangial area and/or endocapillary ...

  4. Pegfilgrastim-jmdb (subcutaneous route) - Mayo Clinic

    Glomerulonephritis (kidney disease) or; Leukocytosis (high white blood cell count) or; Lung disease or breathing problems or; Sickle cell disease (red blood ...

  5. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

    Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay the ...

  6. Publications - Jim T. McCarthy, M.D. - Mayo Clinic

    Risk factors in idiopathic renal vasculitis and glomerulonephritis. Kidney Int. 1989 Dec; 36 (6):1133-41. View PubMed; Nixon DE, Moyer TP, Squillace DP ...

  7. End-stage renal disease - Doctors and departments - Mayo Clinic

    When kidneys no longer function well enough to meet a body's needs, treatment involves kidney dialysis or kidney transplant.

  8. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

    Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay the ...

  9. IgA nephropathy (Berger disease) - Care at Mayo Clinic

    This disease causes kidney inflammation that, over time, can interfere with the kidneys' ability to filter waste from the blood.

  10. Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V - Mayo Clinic

    screening Presence of rapidly progressive glomerulonephritis (RPGN) as defined by 50% decline in eGFR within 3 months prior to screening. Renal biopsy ...